FDA Approves KEYTRUDA for Stage IIB and IIC Melanoma Patients
December 4, 2021 (Richmond, California) Yesterday, Merck announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda…
Blog - Melanoma360
12/04/2021
FDA Approves KEYTRUDA for Stage IIB and IIC Melanoma Patients
December 4, 2021 (Richmond, California) Yesterday, Merck announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda…
|
|
11/17/2021
THE GRATITUDE GALA: AIM’s 3rd Annual No Show Gala & Online Auction
What is a “no-show” gala? AIM at Melanoma’s Third Annual No Show Gala & Auction is a unique fundraiser that…
|
10/07/2021
Relatlimab/Nivolumab Application for Frontline Advanced Melanoma Validated by EMA
October 1, 2021 Kristi Rosa REPOST from OncLive The European Medicines Agency has validated its marketing authorization application for the…
|
|
09/27/2021
Vaccines 2021—Major Advances in Preventing Death from Infection and Malignancy
By Kim Margolin, M.D., FACP, FASCO Vaccine background and brief history The word “vaccine” comes from the Latin word vacca…
|
|
09/26/2021
Using Facebook For Good
One of the most common questions we are asked here at AIM by patients, families, and friends is How can…
|
09/24/2021
FDA Takes Steps Aimed at Improving Quality, Safety and Efficacy of Sunscreens
For Immediate Release: September 24, 2021 (repost from FDA) The U.S. Food and Drug Administration today took steps aimed at…
|
09/24/2021
International Survivor Spotlight: José Correia, Portugal
By Mara Klecker José Correia’s melanoma diagnosis was nearly a quarter-century ago, but he is committed to spreading awareness about…
|
|
09/24/2021
Making the Cut For Melanoma: A Mom’s Motivation
By Mara Klecker As a social service director working in long-term care, Traci Cunningham made a promise to her…
|
|
09/24/2021
President’s Letter | September 2021
From the Desk of Samantha Guild As I reviewed the articles for this month’s newsletter, I thought about the fact…
|
09/24/2021
What is Translational Medicine?
By Maria Libera Ascierto, MS, PhD Associate Professor Translational Cancer Immunology Director “The Rosalie and Harold R Brown Cancer Immunotherapy”…
|
Recent Posts
Nov. 22, 2024
Replimune Receives Breakthrough Therapy Designation for RP1 and Submits BLA to FDA
Nov. 22, 2024
Meaning-Centered Psychotherapy for Cancer Patients
Nov. 05, 2024
Crafting Hope: Chris Krizek’s Journey from Cancer Patient to AIM Fundraiser with Wine Cork Creations
Nov. 04, 2024
Book Suggestions for Caregivers
Oct. 28, 2024